Early Enhancement of Neuroplasticity Index, the Ratio of Serum Brain-Derived Neurotrophic Factor Level to HAMD-24 Score, in Predicting the Long-Term Antidepressant Efficacy
Background: Current mainstream treatment of major depressive disorder (MDD) has a disadvantage in delayed onset of efficacy, making detection of early signatures predicative of the long-term treatment efficacy urgent.Methods: MDD patients were scored with HAMD-24 and serum brain-derived neurotrophic...
Main Authors: | Yuxuan Zhang, Bo Cui, Tianyu Wang, Yan Lu, Zhenlin Chen, Zhilu Zou, Jinlin Miao, Xiuli Zhao, Yonggui Yuan, Haosen Wang, Gang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnbeh.2021.712445/full |
Similar Items
-
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013-12-01) -
Lactate and BDNF: Key Mediators of Exercise Induced Neuroplasticity?
by: Patrick Müller, et al.
Published: (2020-04-01) -
The neuroimmune-neuroplasticity interface and brain pathology.
by: Shawn eHayley
Published: (2014-12-01) -
The role of exercise on cognitive processes and neuroplasticity
by: Đurić Emilija, et al.
Published: (2018-01-01) -
Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-07-01)